Periodyne is a brand of Imagenetix, Inc. (IAGX). Periodyne is a dental product that is used nightly as part of a patient's home care to decrease gingival inflammation and increase gingival health. Periodyne is formulated using a novel, patented and proprietary Cetylated Fatty Acid Complex (CFAC) that significantly reduces intercellular inflammation through the phospholipid enhancement of the cell membrane. CFAC has been shown to modulate systemic oral inflammation. Periodyne has been shown to significantly inhibit chronic oral tissue inflammation. Results of an inflammatory response clinical conducted at Boston University School of Medicine, Department of Periodontology, concluded that Periodyne significantly decreased inflammatory markers contributing to the pathogenesis of periodontal health. Clinical trials show that Periodyne begins to significantly reduce both periodontal pocket depths and bleeding on probing (BOP) in just 2 weeks (West Coast University). There are no known adverse side effects associated with Periodyne. Periodyne is applied in just seconds a day at home after brushing and can be used once at bedtime or more often as recommended by the dental professional.
View Top Employees from PeriodyneWebsite | http://www.periodyne.com |
Revenue | $3 million |
Employees | View employees |
Founded | 2014 |
Industry | Pharmaceutical Manufacturing |
Looking for a particular Periodyne employee's phone or email?
The Periodyne annual revenue was $3 million in 2024.